Menu
Fechar
hrs4r
 I want to donate

BEGOÑA MARTIN CASTILLO

Metabolism and Cancer
Scientific platforms staff
Firma
BEGOÑA MARTIN-CASTILLO
Position
Investigador/a Consolidat - R3
Established Researchers - R3
Projectes
Publicacions

Projectes

Metabolism and Cancer

Ajuts per donar suport a les activitats dels grups de recerca de Catalunya (SGR-Cat 2021) - Metabolisme i càncer

Codi oficial: 2021 SGR 01507 Start date:01/01/2022 Data fi: 30/06/2025 Investigador/a principal: BEGOÑA MARTIN CASTILLO Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER.

Publicacions

Menendez JA, Cuyàs E, Encinar JA, Steen TV, Verdura S, Llop-Hernández À, López J, Serrano-Hervás E, Osuna S, Martin-Castillo B, Lupu R

The Fatty Acid Synthase (FASN) signalome: A molecular guide for precision oncology.

MOLECULAR ONCOLOGY, 2024, 18, 479-516 dx.doi.org/10.1002/1878-0261.13582
Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA

Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin

Pharmaceuticals, 2022, 15 dx.doi.org/10.3390/ph15010019
Cuyàs E, Martin-Castillo B, Menendez JA

Metformin and breast cancer: an opportunity for pharmacogenetics

Aging-Us, 2022, 14, 5612-5613 dx.doi.org/10.18632/aging.204180
Cejuela M, Martin-Castillo B, Menendez JA, Pernas S

Metformin and Breast Cancer: Where Are We Now?

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 dx.doi.org/10.3390/ijms23052705
Tramonti A, Cuyàs E, Encinar JA, Pietzke M, Paone A, Verdura S, Arbusà A, Martin-Castillo B, Giardina G, Joven J, Vazquez A, Contestabile R, Cutruzzolà F, Menendez JA

Metformin Is a Pyridoxal-5 '-phosphate (PLP)-Competitive Inhibitor of SHMT2

Cancers, 2021, 13 dx.doi.org/10.3390/cancers13164009
Cuyàs E, Verdura S, Martin-Castillo B, Menendez JA

Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology

Frontiers in oncology, 2021, 10, 620641-620641 dx.doi.org/10.3389/fonc.2020.620641
Cuyàs E, Verdura S, Martin-Castillo B, Alarcón T, Lupu R, Bosch-Barrera J, Menendez JA

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy

Cancers, 2020, 12 dx.doi.org/10.3390/cancers12071757
Cuyàs E, Gumuzio J, Verdura S, Brunet J, Bosch-Barrera J, Martin-Castillo B, Alarcón T, Encinar JA, Martin ÁG, Menendez JA

The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes

Aging-Us, 2020, 12, 4794-4814 dx.doi.org/10.18632/aging.102887
Verdura S, Cuyàs E, Cortada E, Brunet J, Lopez-Bonet E, Martin-Castillo B, Bosch-Barrera J, Encinar JA, Menendez JA

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

Aging-Us, 2020, 12, 8-34 dx.doi.org/10.18632/aging.102646
Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA

Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients

Journal of Clinical Medicine, 2020, 9 dx.doi.org/10.3390/jcm9061770

Formulari de contacte

About IDIBGI!

 menu